US › Healthcare

Orthofix Medical Inc (OFIX)

US · Healthcare · Medical Devices

$7.87-11.77%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$210.9M

Revenue YoY

+3.8%

Net profit

$-15.8M

EPS

$-0.39

EPS estimate

$-0.46

Net margin

-7.5%

EPS came in at -0.39 against a street estimate of -0.46 — a beat of 15.2%.

Key statistics

Market cap

$360.6M

Forward P/E

500.0

P/B

0.92

Book value

$10.54

EPS (TTM)

$-1.52

52-week high

$16.42

52-week low

$7.81

50-day MA

$9.34

200-day MA

$11.02

Beta

0.64

Analyst view

Analysts rate Orthofix Medical Inc a buy (3 buy, 1 hold, 0 sell out of 4) with an average price target of $13.00.

Shareholding

Insiders

2.17%

Institutions

96.12%

Largest institutional holders

Fund	Stake
Engine Capital Management LP	11.23%
Juniper Investment Co, LLC	10.91%
Rubric Capital Management LP	9.14%
BlackRock Inc	8.17%
Paradigm Capital Management, Inc.	8.10%
Armistice Capital, LLC	8.01%
Vanguard Capital Management, LLC	4.25%
Geode Capital Management, LLC	2.57%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Orthofix Medical Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.